Accolade shares are trading lower after the company reported Q2 financial results and issued Q3 guidance. Also, Raymond James and Truist Securities lowered their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
Accolade's shares are trading lower following the release of its Q2 financial results and Q3 guidance. Additionally, Raymond James and Truist Securities have reduced their price targets for the stock.
October 05, 2023 | 3:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Accolade's stock price is expected to decrease in the short term due to disappointing Q2 results and Q3 guidance, as well as lowered price targets by Raymond James and Truist Securities.
Accolade's Q2 financial results and Q3 guidance were not well-received by the market, leading to a drop in its stock price. Additionally, lowered price targets by Raymond James and Truist Securities indicate a negative outlook for the stock, further pressuring the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100